Data / Form D filings / Topo Therapeutics, Inc.
Topo Therapeutics, Inc.: Form D filings
Topo Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC in 2024. The latest, on December 31, 2024, reports $10.6 million sold of a $95 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE KENDALL SQUARE, BUILDING 1400, SUITE 14-101, Cambridge, MA, 02139
- Phone
- (857) 331-6825
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2049947
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | Amendment | $95,000,000 | $10,555,558 | $84,444,442 | 4 | Dec 17, 2024 | sec.gov |
| Dec 30, 2024 | New notice | $95,000,000 | $10,555,558 | $84,444,442 | 4 | Dec 17, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bruce Jeffrey Bean | Director | |
| Hui Tian | Executive Officer, Director | |
| Madgalene Moran | Executive Officer, Director | |
| Karin Jeffrey Kleinhans | Director | |
| James Jeffrey Goater, Jr. | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 30, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Topo Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.